KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Medpace Holdings (MEDP) EBIAT (2016 - 2025)

Historic EBIAT for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $135.1 million.

  • Medpace Holdings' EBIAT rose 1548.05% to $135.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $451.1 million, marking a year-over-year increase of 1155.75%. This contributed to the annual value of $451.1 million for FY2025, which is 1155.75% up from last year.
  • Medpace Holdings' EBIAT amounted to $135.1 million in Q4 2025, which was up 1548.05% from $111.1 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' EBIAT peaked at $135.1 million during Q4 2025, and registered a low of $39.9 million during Q2 2021.
  • Moreover, its 5-year median value for EBIAT was $71.7 million (2023), whereas its average is $78.3 million.
  • The largest annual percentage gain for Medpace Holdings' EBIAT in the last 5 years was 6567.37% (2021), contrasted with its biggest fall of 163.57% (2021).
  • Over the past 5 years, Medpace Holdings' EBIAT (Quarter) stood at $50.0 million in 2021, then soared by 37.25% to $68.7 million in 2022, then increased by 14.02% to $78.3 million in 2023, then skyrocketed by 49.45% to $117.0 million in 2024, then rose by 15.48% to $135.1 million in 2025.
  • Its EBIAT stands at $135.1 million for Q4 2025, versus $111.1 million for Q3 2025 and $90.3 million for Q2 2025.